Gliricidia sepium Aqueous Leaf Extract Possesses Antisickling Property
Journal Title: International Blood Research & Reviews - Year 2016, Vol 5, Issue 3
Abstract
Background: Extracts of leaf, flower and bark of Gliricidia sepium have been used in the treatment of patients with pathogenic bacterial infections, skin diseases, nematodes and antioxidants disturbances. We recently had information of its use in the treatment of sickle cell disease in some parts of Nigeria. Aim: The aim of this study is to investigate the in-vitro antisickling properties of Gliricidia sepium aqueous leaf extract. Place and Duration of the Study: This study was carried out in the Department of Chemical Pathology, Faculty of Medical Laboratory Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria. Methods: Air-dried leaves were ground and an aliquot, 100 g was extracted by maceration in 1.0 L of distilled water as solvent for 72 h with periodic stirring. The same procedure was repeated with residues and the mixture was filtered and concentrated to dryness. Different concentrations (5 mg, 10 mg, 15 mg, 20 mg, 25 mg, 30 mg, 35 mg, 40 mg, 45 mg and 50 mg) were made from the extract and then tested for their antisickling activities against haemoglobin SS blood using freshly prepared 2% sodium metabisulphite. Results: Our findings revealed strong antisickling activity; 20% antisckling at 5 mg, 50% at 10 mg, 80% at 15 mg and 100% antisickling from 20 mg upward for the leaf extract. Conclusion: It has been shown for the first time, from this study that aqueous extract of Gliricidia sepium has strong antisickling properties justifying its use by the herbalists in the management of sickle cell disease. Toxicity studies, isolation and characterization of active compound are on-going in our laboratories.
Authors and Affiliations
T. Oduola, M. K. Dallatu, A. O. Muhammed, I. M. Adebisi, S. W. Hassan
A Case Report of Pregnant Woman with Aplastic Anemia: Diagnosis and Management through Subsequent Pregnancy
Introduction: Aplastic anemia is characterized by decreased bone marrow function with inadequate production of erythrocytes, granulocytes, and platelets. Marrow failure may be caused by absence of or defects in hematopoi...
Effects of Co-infusion of Plasma, Whole Blood and Anticogulants on Their Clotting Activities
Aims: Nafamostat mesilate (NM), a protease inhibitor is available for treating acute pancreatitis and disseminated intravascular coagulopathy and it is used as an anticoagulant for hemodialysis in Japan. A plasmapheresis...
Effect of HbF Level among Different Severity of Sickle Cell Disease
Background: Fetal hemoglobin (HbF) can inhibit the deoxygenation induced polymerization of sickle hemoglobin (HbS) that drives the Pathophysiology of sickle cell disease. The aim of this study was to determine fetal Hb l...
Donor Deferral Patterns at a Hospital-based Blood Bank in Saudi Arabia
Aims: This study analysed the blood donors deferral patterns at a government hospital blood bank in Saudi Arabia. The proportion and reasons of deferrals were also investigated. Methodology: Retrospective review was done...
Assessment of CD4 Count and Some Haematological Parameters of HIV Positive Patients Co-infected with Hepatitis B Virus in Osun State, Nigeria
Background: Increased morbidity and mortality rates have been reported among patients co-infected with Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV). Aims: To determine the prevalence of HBV infection am...